A股收評:持續下挫!深成指、創業板指均跌逾1.5%,成交額連續4日低於6000億元
A股主要指數今日繼續下挫,深成指、創業板指均跌逾1.5%;截至收盤,滬指跌0.93%報2922點錄得3連跌,深證成指跌1.54%,創業板指跌1.62%。超4800股下跌,全天成交5820億元,為連續4日低於6000億元。盤面上,數字哨兵、數字貨幣板塊下挫,雄帝科技跌近13%;人腦工程板塊走低,聲迅股份跌超8%;長壽藥板塊走弱,普利製藥20cm跌停;教育板塊震盪下行,學大教育逼近跌停;國產軟件、短劇概念及多模態AI等板塊跌幅居前。另外,雞肉概念、食品安全板塊小幅上升,華英農業升停。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.